Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199

<p>Credits: 0.25 AMA PRA Category 1 Credits™</p> <p>Claim CME/CE credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184"> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199</a></p> <p>Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.</p> <p>Guest: Alan Ehrlich, MD</p> <p>Music Credit: Richard Onorato</p>